Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Indian researchers patent ENPP1 inhibitors

April 9, 2021

FDA places partial clinical hold on first-in-human study of RVU-120

April 9, 2021

Patient dosing starts in first-in-human study of DS-1594 as treatment of AML and ALL

April 9, 2021

Premetastatic niche is prepared via leaky gut in colorectal cancer

April 9, 2021

Stearoyl-CoA-desaturase inhibitor YTX-7739 shows efficacy in glioblastoma mouse models

April 8, 2021

Patient recruitment ongoing in phase III study of Tookad VTP in upper tract urothelial carcinoma

April 8, 2021

RMC-5552 enters phase I development for relapsed/refractory solid tumors

April 8, 2021

Calico and AbbVie initiate first-in-human study of ABBV-CLS-484

April 8, 2021

Cell Biotech divulges vector constructs for colon cancer

April 8, 2021

First cohort fully enrolled in WWRD Study of AVM-0703

April 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....